Evidence map›Paper›PMID 34424945›Full record

ArticlePLoS pathogens2021

Acute SARS-CoV-2 infections harbor limited within-host diversity and transmit via tight transmission bottlenecks.

Katarina M Braun, Gage K Moreno, Cassia Wagner, Molly A Accola, William M Rehrauer, David A Baker, Katia Koelle, David H O'Connor, Trevor Bedford, Thomas C Friedrich and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 122 citations in OpenAlex.

  1. Article
  2. The other immune landscape of SARS-CoV-2 evolution.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Katarina M BraunDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.ORCID 0000-0003-3612-9319
Gage K MorenoDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.ORCID 0000-0003-4738-5318
Cassia WagnerVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.ORCID 0000-0002-9934-7578
Molly A AccolaUniversity of Wisconsin School of Medicine and Public Health and the William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, United States of America.ORCID 0000-0001-6904-7171
William M RehrauerUniversity of Wisconsin School of Medicine and Public Health and the William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, United States of America.
David A BakerDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.ORCID 0000-0002-6811-8238
Katia KoelleDepartment of Biology, Emory University, Atlanta, Georgia, United States of America.ORCID 0000-0002-0254-6141
David H O'ConnorDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.ORCID 0000-0003-2139-470X
Trevor BedfordVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.ORCID 0000-0002-4039-5794
Thomas C FriedrichDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.ORCID 0000-0001-9831-6895
Louise H MonclaVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.ORCID 0000-0001-5722-1988
University of Wisconsin–Madison · USFred Hutch Cancer Center · USWilliam S. Middleton Memorial Veterans Hospital · USEmory University · US

Funding

Research Training for Computation and Informatics in Biology and MedicineT15LM007359 · NLM · UNIVERSITY OF WISCONSIN-MADISON · PI Mark W. Craven, Colin Noel Dewey · 2002 to 2026
$22.6M
INTEGRATED TRAINING FOR PHYSICIAN-SCIENTISTST32GM008692 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BURKARD, MARK E · 1998 to 2020
$10.3M
Integrated Training For Physician-ScientistsT32GM140935 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Anna Huttenlocher, Jeniel E Nett · 2021 to 2026
$6.5M
Quantifying the genetic and environmental factors driving avian influenza spilloverR00AI147029 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI MONCLA, LOUISE HILLIER · 2022 to 2023
$498k
Quantifying the genetic and environmental factors driving avian influenza spilloverK99AI147029 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MONCLA, LOUISE HILLIER · 2020 to 2021
$257k
Defining the role of genetic drift in within-host influenza evolutionF30AI145182 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI BRAUN, KATARINA M · 2020 to 2022
$95k
NIAID NIH HHS F30 AI145182NIAID NIH HHS K99 AI147029NIAID NIH HHS R00 AI147029NIGMS NIH HHS T32 GM008692NIGMS NIH HHS T32 GM140935NLM NIH HHS T15 LM007359
6 · The paper itself

Abstract

The emergence of divergent SARS-CoV-2 lineages has raised concern that novel variants eliciting immune escape or the ability to displace circulating lineages could emerge within individual hosts. Though growing evidence suggests that novel variants arise during prolonged infections, most infections are acute. Understanding how efficiently variants emerge and transmit among acutely-infected hosts is therefore critical for predicting the pace of long-term SARS-CoV-2 evolution. To characterize how within-host diversity is generated and propagated, we combine extensive laboratory and bioinformatic controls with metrics of within- and between-host diversity to 133 SARS-CoV-2 genomes from acutely-infected individuals. We find that within-host diversity is low and transmission bottlenecks are narrow, with very few viruses founding most infections. Within-host variants are rarely transmitted, even among individuals within the same household, and are rarely detected along phylogenetically linked infections in the broader community. These findings suggest that most variation generated within-host is lost during transmission.

Indexed as

Genetic VariationAcute DiseaseCOVID-19Evolution, MolecularGenome, ViralHumansPhylogenySARS-CoV-2Time Factors

Identifiers

PMID34424945
PMCPMC8412271
OpenAlexW3194572293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.